![]() |
|
|
DD Schwartz and KU Malik
Department of Pharmacology, University of Tennessee, Memphis.
In the isolated rat kidney, the vasoconstrictor response elicited by periarterial nerve stimulation at low frequencies (2 Hz) is resistant to alpha adrenergic receptor blockade. It has been proposed that in some blood vessels ATP is coreleased with norepinephrine during nerve stimulation to activate P2-purinergic receptors and is responsible for the component of the vasoconstrictor response that is resistant to alpha adrenergic receptor blockade. To assess the contribution of a purinergic transmitter in the vasoconstriction elicited by periarterial nerve stimulation in the isolated Tyrodes-perfused rat kidney, fractional overflow of [3H]norepinephrine and vasoconstrictor responses to renal nerve stimulation were examined after alpha adrenergic receptor blockade and/or P2-purinergic receptor desensitization. The alpha-1 adrenergic receptor antagonists prazosin (0.1-1.0 microM) and corynanthine (0.1-1.0 microM) and the nonselective alpha adrenergic receptor antagonist phentolamine (0.1-1.0 microM) did not significantly reduce vasoconstrictor responses elicited by low frequency (0.5-4 Hz) but attenuated the responses to high-frequency (6-10 Hz) periarterial nerve stimulation. At low-frequency renal nerve stimulation, selective P2-purinergic receptor desensitization abolished the vasoconstriction at 0.5 Hz and dramatically attenuated the responses up to 4 Hz. In the presence of prazosin, the component of the vasoconstrictor response that was resistant to alpha adrenergic receptor blockade at all frequencies of renal nerve stimulation was abolished after treatment with alpha, beta-methylene ATP. On the other hand, in the isolated perfused rabbit kidney, prazosin (1.0 microM) alone reduced dramatically the vasoconstrictor responses to periarterial nerve stimulation over the same frequencies used in the rat.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, E. W. Inscho, M. Bondlela, J. R. Falck, and J. D. Imig The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2089 - H2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Inscho P2 receptors in regulation of renal microvascular function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F927 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. van der Weyden, D. J. Adams, and B. J. Morris Capacity for Purinergic Control of Renin Promoter via P2Y11 Receptor and cAMP Pathways Hypertension, December 1, 2000; 36(6): 1093 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salomonsson, K. Brannstrom, and W. J. Arendshorst alpha 1-Adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies Am J Physiol Renal Physiol, January 1, 2000; 278(1): F138 - F147. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Stauss, J.-U. Stegmann, P. B. Persson, and H.-J. Habler Frequency response characteristics of sympathetic transmission to skin vascular smooth muscles in rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R591 - R600. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. OBERHAUSER, O. VONEND, and L. C. RUMP Neuropeptide Y and ATP Interact to Control Renovascular Resistance in the Rat J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1179 - 1185. [Abstract] [Full Text] |
||||
![]() |
E. W. Inscho, A. K. Cook, V. Mui, and J. Miller Direct assessment of renal microvascular responses to P2-purinoceptor agonists Am J Physiol Renal Physiol, April 1, 1998; 274(4): F718 - F727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bohmann, L. C. Rump, U. Schaible, and I. von Kugelgen {alpha}-Adrenoceptor Modulation of Norepinephrine and ATP Release in Isolated Kidneys of Spontaneously Hypertensive Rats Hypertension, June 1, 1995; 25(6): 1224 - 1231. [Abstract] [Full Text] |
||||
![]() |
E. W. Inscho and A. K. Cook P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade Am J Physiol Renal Physiol, February 1, 2002; 282(2): F245 - F255. [Abstract] [Full Text] [PDF] |
||||